Interobserver variability in the interpretation of Papanicolaou tests using the Hologic Genius Digital Diagnostics System: detailed analysis of cytology verification in a large academic laboratory
- 10 October 2026
- journal article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 166 (4)
Abstract
Objectives: Whole-slide digital imaging technology paired with artificial intelligence is transforming the practice of cervical cancer screening. We aimed to evaluate the performance of the Hologic Genius Digital Diagnostics System (HGDDS) for detection of neoplasia and to investigate interobserver variability among users who have undergone HGDDS training. Methods: A total of 110 ThinPrep Papanicolaou tests were selected, with original diagnoses that included 47 cases of low-grade squamous intraepithelial lesion or worse (LSIL+); 4 cases of unsatisfactory findings; and 59 cases negative for intraepithelial lesion or malignancy (NILM), including 23 cases with microorganisms. All cases were reviewed by 16 cytologists or cytopathologists using the HGDDS. Interobserver variability and correlation with original diagnoses were assessed. Results: The HGDDS showed greater than 95% sensitivity, specificity, positive predictive value, negative predictive value, and accuracy for LSIL+ disease. The overall misinterpretation rate was 5.5%. In total, 3 cases had poor interpretation (≥7/16 misinterpretations), including a high-grade squamous intraepithelial lesion case with 2 adenocarcinoma responses, an LSIL response, and 4 unsatisfactory responses, as well as 2 NILM cases interpreted as unsatisfactory by most participants due to borderline cellularity. Of 23 cases with microorganisms, organisms were not present in the 60-image gallery for 4 cases. Sensitivity was highest for Trichomonas (93.8%) but was low for other microorganisms (58.9%-68.8%). Conclusions: In a large academic cytology laboratory, HGDDS review by trained users demonstrated high concordance with adjudicated diagnoses for detection of LSIL+, supporting its effectiveness for identifying epithelial abnormalities. However, user experience with digital morphology is important. During early implementation, laboratories should monitor discordance and consider temporary dual review, with particular attention to borderline cellularity cases and microorganism detection.Keywords
This publication has 14 references indexed in Scilit:
- Evaluation of the Hologic Genius Digital Diagnostics System for clinical use in Papanicolaou test interpretation: a validation study of 1748 casesJournal of the American Society of Cytopathology, 2026
- Papanicolaou test interpretation utilizing the Hologic Genius Digital Diagnostics System vs manual glass slide review: A retrospective study of 596 casesAmerican Journal of Clinical Pathology, 2025
- Assessment of the efficacy and accuracy of cervical cytology screening with the Hologic Genius Digital Diagnostics SystemCancer Cytopathology, 2025
- The clinical significance of atypical glandular cells in Papanicolaou tests: changes in diagnostic patterns over 15 years at a single institutionJournal of the American Society of Cytopathology, 2025
- American Society of Cytopathology’s cytopathology workforce survey in the United StatesJournal of the American Society of Cytopathology, 2024
- Analysis of the sensitivity of high‐grade squamous intraepithelial lesion Pap diagnosis and interobserver variability with the Hologic Genius Digital Diagnostics SystemCancer Cytopathology, 2024
- Validation of AI-assisted ThinPrep® Pap test screening using the GeniusTM Digital Diagnostics SystemJournal of Pathology Informatics, 2024
- Comparison of the Hologic Genius Digital Diagnostics System with the ThinPrep Imaging System—A retrospective assessmentCancer Cytopathology, 2023
- Changes over time in papanicolaou cytology test and HPV test in a large women’s academic center laboratoryJournal of the American Society of Cytopathology, 2023
- Pathway to the Papanicolaou smear: The development of cervical cytology in twentieth-century America and implications in the present dayGynecologic Oncology, 2019